Good news for retention of women on option B+ in Malawi-Reference-Cited by-同舟云学术

Good news for retention of women on option B+ in Malawi

Published:2016-04 Issue:4 Volume:3 Page:e151-e152
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Sibanda Euphemia L,Cowan Frances M

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference12 articles.

1. Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants,2010

2. Is Option B+ the best choice?;Coutsoudis;Lancet,2013

3. Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants,2012

4. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach,2013

5. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi;Tenthani;AIDS,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Programmatic Retention in Prevention of Mother-to-Child Transmission (PMTCT) Programs: Estimated Rates and Cofactors Using Different Nonretention Measures;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-02-01

2. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study;BMC Infectious Diseases;2018-10-24

3. Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-04-15